Suppr超能文献

隐源性机化性肺炎。48例患者系列复发特征。肺“孤儿”病研究小组(GERM"O"P)

Cryptogenic organizing pneumonia. Characteristics of relapses in a series of 48 patients. The Groupe d'Etudes et de Recherche sur les Maladles "Orphelines" Pulmonaires (GERM"O"P).

作者信息

Lazor R, Vandevenne A, Pelletier A, Leclerc P, Court-Fortune I, Cordier J F

机构信息

Centre d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires, Hôpital Cardiovasculaire et Pneumologique Louis Pradel, Université Claude Bernard, Hospices Civils de Lyon, Lyon, France.

出版信息

Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):571-7. doi: 10.1164/ajrccm.162.2.9909015.

Abstract

Cryptogenic organizing pneumonia (COP) is a clinicopathologic syndrome characterized by rapid resolution with corticosteroids, but frequent relapses when treatment is tapered or stopped. We retrospectively studied relapses in 48 cases of biopsy-proven COP. One or more relapses (mean 2.4 +/- 2.2) occurred in 58%. At first relapse, 68% of patients were still under treatment for the initial episode. Compared with the no-relapse group, nine patients with multiple (>/= 3) relapses had longer delays between first symptoms and treatment onset (22 +/- 17 versus 11 +/- 8 wk, p = 0.02), and elevated gamma-glutamyltransferase (124 +/- 98 versus 29 +/- 13 IU/L, p = 0.001) and alkaline phosphatase (190 +/- 124 versus 110 +/- 68 IU/L, p = 0.04) levels. Relapses did not adversely affect outcome. Corticosteroid treatment side effects occurred in 25% of patients. Standardized treatment in 14 patients allowed a reduction of prednisone cumulated doses (p < 0.05) without affecting outcome or relapse rate. We conclude that: (1) delayed treatment increases the risk of relapses; (2) mild cholestasis identifies a subgroup of patients with multiple relapses; (3) relapses do not affect outcome, and prolonged therapy to suppress relapses appears unnecessary; (4) a standardized treatment allows a reduction in steroid doses.

摘要

隐源性机化性肺炎(COP)是一种临床病理综合征,其特征为使用糖皮质激素治疗后可迅速缓解,但在治疗减量或停药时频繁复发。我们对48例经活检证实的COP患者的复发情况进行了回顾性研究。58%的患者出现了一次或多次复发(平均2.4±2.2次)。首次复发时,68%的患者仍在接受初始发作的治疗。与无复发组相比,9例多次(≥3次)复发的患者在首次症状出现至开始治疗之间的延迟时间更长(22±17周对11±8周,p = 0.02),γ-谷氨酰转移酶(124±98对29±13 IU/L,p = 0.001)和碱性磷酸酶(190±124对110±68 IU/L,p = 0.04)水平升高。复发对预后无不良影响。25%的患者出现了糖皮质激素治疗的副作用。14例患者接受标准化治疗后,泼尼松累积剂量得以减少(p < 0.05),且未影响预后或复发率。我们得出以下结论:(1)延迟治疗会增加复发风险;(2)轻度胆汁淤积可识别出多次复发的患者亚组;(3)复发不影响预后,似乎无需延长治疗以抑制复发;(4)标准化治疗可减少类固醇剂量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验